Drugs / Lactobacilli rhamnosus GR-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04638257 | Jan 2013 → Mar 2015 | bacterial vaginosis | The University of Texas Medical Branch, Galveston | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacilli rhamnosus GR-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04638257 ↗ |
| Route | Oral | “oral administrations of these strains of lactobacilli are safe” NCT04638257 ↗ |